uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
No Benefit of Ticagrelor Pretreatment Compared With Treatment During Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Lund Univ, Skane Univ Hosp Lund, Dept Cardiol, Lund, Sweden;Lund Univ, Skane Univ Hosp Lund, Dept Clin Sci, Lund, Sweden.
Lund Univ, Skane Univ Hosp Lund, Dept Cardiol, Lund, Sweden;Lund Univ, Skane Univ Hosp Lund, Dept Clin Sci, Lund, Sweden.
Lund Univ, Skane Univ Hosp Lund, Dept Cardiol, Lund, Sweden;Lund Univ, Skane Univ Hosp Lund, Dept Clin Sci, Lund, Sweden.
Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden.
Show others and affiliations
2018 (English)In: Circulation. Cardiovascular Interventions, ISSN 1941-7640, E-ISSN 1941-7632, Vol. 11, no 3, article id e005528Article in journal (Refereed) Published
Abstract [en]

Background-The effects of ticagrelor pretreatment in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention (PCI) is debated. This study investigated the effects of ticagrelor pretreatment on clinical outcomes in this patient group.

Methods and Results-Patients with ST-segment-elevation myocardial infarction undergoing primary PCI were included from October 2010 to October 2014 in Sweden. Screening was done using the SWEDEHEART register (Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies). A total of 7433 patients were included for analysis with 5438 patients receiving ticagrelor pretreatment and 1995 patients with ticagrelor given only in the catheterization laboratory. The primary end point of the study was 30-day event rates of a composite of all-cause mortality, myocardial infarction (MI), and stent thrombosis. Secondary end points were mortality, MI, or stent thrombosis alone and major in-hospital bleeding. Crude event rates showed no difference in 30-day composite end point (6.2% versus 6.5%; P=0.69), mortality (4.5% versus 4.7%; P=0.86), MI (1.6% versus 1.7%; P=0.72), or stent thrombosis (0.5% versus 0.4%; P=0.80) with ticagrelor pretreatment. Three different statistical models were used to correct for baseline differences. No difference in the composite end point, mortality, MI, or stent thrombosis was seen between the 2 groups after statistical adjustment. No increase in in-hospital major bleeding rate was observed with ticagrelor pretreatment.

Conclusions-Ticagrelor pretreatment versus ticagrelor given in the catheterization laboratory in patients with ST-segment-elevation myocardial infarction undergoing primary PCI did not improve the composite end point of all-cause mortality or MI or stent thrombosis or its individual components at 30 days.

Place, publisher, year, edition, pages
LIPPINCOTT WILLIAMS & WILKINS , 2018. Vol. 11, no 3, article id e005528
Keywords [en]
myocardial infarction, percutaneous coronary intervention, ST-elevation myocardial infarction, stents, thrombosis
National Category
Cardiac and Cardiovascular Systems
Identifiers
URN: urn:nbn:se:uu:diva-359674DOI: 10.1161/CIRCINTERVENTIONS.117.005528ISI: 000435566100002PubMedID: 29870381OAI: oai:DiVA.org:uu-359674DiVA, id: diva2:1246768
Funder
Swedish Heart Lung FoundationAvailable from: 2018-09-10 Created: 2018-09-10 Last updated: 2019-01-21Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records BETA

Lagerqvist, BoJames, Stefan K

Search in DiVA

By author/editor
Lagerqvist, BoJames, Stefan K
By organisation
UCR-Uppsala Clinical Research CenterDepartment of Medical Sciences
In the same journal
Circulation. Cardiovascular Interventions
Cardiac and Cardiovascular Systems

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 3 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf